Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the efficacy, safety, and pharmacokinetics of an R-ketamine hydrochloride nasal spray in adults with major depressive disorder and acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R-ketamine hydrochloride nasal spray (R-ketamine hydrochloride)

Snippet

Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. | Conditions: Major Depressive Disorder (MDD | Phase 2 | Status: RECRUITING